HFE and Alzheimer disease: Then, a number of studies followed that explored the role of HFE mutations in AD risk, reporting significant associations with AD features, for example, disease onset [123,124], cognitive symptoms [125], the severity of clinical deficits [126], markers in the CSF [76], and conversion from mild cognitive impairment (MCI) to AD [125].